Latest Regulatory Framework News

Delta Lithium has issued a formal correction disputing a $93 billion in-ground valuation of rubidium at its Mt Ida project reported by the Australian Financial Review, citing JORC Code compliance. The company urges investors to disregard the figure and requests resumption of trading.

eMetals Limited has inked a binding deal to acquire the Mineral Range Tungsten Project in Utah, marking a strategic move into a critical mineral with robust exploration potential. The company is poised to launch a comprehensive exploration program targeting high-grade tungsten deposits in a mining-friendly US jurisdiction.

The High Court of Asturias has upheld a municipal council's procedural ruling against EMC Gold’s urban plan amendment for the Salave Gold Project, leaving the project’s technical merits untouched. EMC Gold signals ongoing stakeholder engagement and alternative development strategies ahead.

PT Aneka Tambang Tbk (ANTAM) reported a historic financial year in 2025, with revenue up 22% and net profit more than doubling to Rp7.92 trillion, driven by strong domestic demand and operational efficiency. The company also navigates evolving Indonesian mining regulations and ongoing legal challenges as it invests in downstream nickel projects.

iCandy Interactive confirms its removal from the ASX on 1 April 2026, shifting focus to a potential NYSE American listing for its key asset, Lemon Sky Studios.

Challenger Limited has welcomed APRA’s new capital framework for longevity products, set to ease capital requirements and reduce risk for providers, supporting Australia’s evolving retirement income market.

Optiscan Imaging Ltd has taken a significant step towards commercialising its InSpecta® veterinary imaging device in the US by submitting a regulatory dossier to the FDA. This milestone not only initiates formal review but also sets the stage for broader clinical adoption and future device approvals.

Nexsen Limited's subsidiary has won a HK$6 million grant to accelerate clinical validation and manufacturing of its rapid Group B Streptococcus diagnostic in Hong Kong, positioning the city as a key Asia-Pacific hub.

Temas Resources Corp has opted to reduce its financial reporting frequency, moving from quarterly to semi-annual reports under a Canadian Securities Exchange pilot program. This change aligns with its status as a venture issuer and reflects its ongoing focus on proprietary processing technology and mineral projects.

QX Resources has obtained the last two exploration licences for its Madaba Uranium Project in Tanzania, paving the way for a high-resolution survey and maiden drilling program. The company is well-funded and advancing environmental assessments to meet regulatory requirements.

Unity Metals has reported promising high-grade gold intersections from initial drilling at its Ngot Gold Project, with assays confirming mineralisation similar to the nearby Okvau Mine. The ongoing 8,000m drilling program is progressing well, with further results eagerly awaited.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.